Activation of a retinoic acid receptor pathway by thiazolidinediones induces production of vascular endothelial growth factor/vascular permeability factor in OP9 adipocytes

European Journal of Pharmacology

Volumn 707, Issue 1-3, 2013, Pages 95-103

  Kotake, Daisuke ^a   Hirasawa, Noriyasu ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Adipocyte; Edema; PPAR ; RAR; Vascular permeability; VEGF

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 2 CHLORO 5 NITROBENZANILIDE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLSALICYLIC ACID; GINKGOLIC ACID; HYPOXIA INDUCIBLE FACTOR; INDOMETACIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; RETINOIC ACID; RETINOIC ACID RECEPTOR BETA; TRANSCRIPTION FACTOR ETS 1; TROGLITAZONE; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL HYPOXIA; CELL STRAIN; CELL STRAIN OP9; CONTROLLED STUDY; DOWN REGULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; TRANSCRIPTION REGULATION; UPREGULATION;

ADIPOCYTES; ANIMALS; ASPIRIN; CAPILLARY PERMEABILITY; CELL DIFFERENTIATION; CELLS, CULTURED; CHROMANS; EDEMA; GENE EXPRESSION REGULATION; GUINEA PIGS; HYPOGLYCEMIC AGENTS; INDOMETHACIN; MALE; MICE; PPAR GAMMA; RECEPTORS, RETINOIC ACID; THIAZOLIDINEDIONES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84876162076     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.03.033     Document Type: Article

References (45)

1. G. Allenby, M.T. Bocquel, M. Saunders, S. Kazmer, J. Speck, M. Rosenberger, A. Lovey, P. Kastner, J.F. Grippo, P. Chambon, and A.A. Levin Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids Proc. Nat. Acad. Sci. U.S.A. 90 1993 30 34
2. H. Bamba, S. Ota, A. Kato, C. Kawamoto, and K. Fujiwara Prostaglandins up-regulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells Biochem. Biophys. Res. Commun. 273 2000 485 491
3. H.D. Berlie, J.S. Kalus, and L.A. Jaber Thiazolidinediones and the risk of edema: a meta-analysis Diabetes Res. Clin. Pract. 76 2007 279 289
4. C.G. Brook, J.K. Lloyd, and O.H. Wolf Relation between age of onset of obesity and size and number of adipose cells Br. Med. J. 2 1972 25 27
5. B. Cariou, B. Charbonnel, and B. Staels Thiazolidinediones and PPARγ agonists: time for a reassessment Trends Endocrinol. Metabol. 23 2012 205 215
6. C.H. Cho, Y.J. Koh, J. Han, H.K. Sung, H.J. Lee, T. Morisada, R.A. Schwendener, R.A. Brekken, G. Kang, Y. Oike, T.S. Choi, T. Suda, O.J. Yoo, and G.Y. Koh Angiogenic role of LYVE-1-positive macrophages in adipose tissue Circ. Res. 100 2007 e47 e57
7. P.D. Collins, D.T. Connolly, and T.J. Williams Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo Br. J. Pharmacol. 109 1993 195 199
8. H. de Thé, M.M. Vivanco-Ruiz, P. Tiollais, H. Stunnenberg, and A. Dejean Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene Nature 343 1990 177 180
9. H.F. Dvorak, J.A. Nagy, B. Berse, L.F. Brown, K.T. Yeo, T.K. Yeo, A.M. Dvorak, L. van de Water, T.M. Sioussat, and D.R. Senger Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation Ann. N.Y. Acad. Sci. 667 1992 101 111
10. I. Elias, S. Franckhauser, T. Ferré, L. Vilà, S. Tafuro, S. Muñoz, C. Roca, D. Ramos, A. Pujol, E. Riu, J. Ruberte, and F. Bosch Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance Diabetes 61 2012 1801 1813
11. M. Emoto, T. Anno, Y. Sato, K. Tanabe, S. Okuya, Y. Tanizawa, A. Matsutani, and Y. Oka Troglitazone treatment increases plasma vascular endothelial growth factor in diabetic patients and its mRNA in 3T3-L1 adipocytes Diabetes 50 2001 1166 1170
12. M. Emoto, N. Fukuda, Y. Nakamori, A. Taguchi, S. Okuya, Y. Oka, and Y. Tanizawa Plasma concentrations of vascular endothelial growth factor are associated with peripheral oedema in patients treated with thiazolidinedione Diabetologia 49 2006 2217 2218
13. Y. Endo, M. Suzuki, H. Yamada, S. Horita, M. Kunimi, O. Yamazaki, A. Shirai, M. Nakamura, N. Iso-O, Y. Li, M. Hara, K. Tsukamoto, N. Moriyama, A. Kudo, H. Kawakami, T. Yamauchi, N. Kubota, T. Kadowaki, H. Kume, Y. Enomoto, Y. Homma, G. Seki, and T. Fujita Thiazolidinediones enhance sodium-coupled bicarbonate absorption from renal proximal tubules via PPARγ-dependent nongenomic signaling Cell Metab. 13 2011 550 561
14. S.K. Fried, D.A. Bunkin, and A.S. Greenberg Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid J. Clin. Endocrinol. Metab. 83 1998 847 850
15. Y. Guan, C. Hao, D.R. Cha, R. Rao, W. Lu, D.E. Kohan, M.A. Magnuson, R. Redha, Y. Zhang, and M.D. Breyer Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption Nat. Med. 11 2005 861 866
16. S. Hallakou, L. Doaré, F. Foufelle, M. Kergoat, M. Guerre-Millo, M.F. Berthault, I. Dugail, J. Morin, J. Auwerx, and P. Ferré Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat Diabetes 46 1997 1393 1399
17. G. Helmlinger, F. Yuan, M. Dellian, and R.K. Jain Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation Nat. Med. 3 1997 177 182
18. I. Idris, G. Warren, and R. Donnelly Association between thiazolidinedione treatment and risk of macular edema among patients with type 2 diabetes Arch. Intern. Med. 172 2012 1005 1011
19. M. Iwaki, M. Matsuda, N. Maeda, T. Funahashi, Y. Matsuzawa, M. Makishima, and I. Shimomura Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors Diabetes 52 2003 1655 1663
20. S.Y. James, F. Lin, S.K. Kolluri, M.I. Dawson, and X.K. Zhang Regulation of retinoic acid receptor beta expression by peroxisome proliferator- activated receptor gamma ligands in cancer cells Cancer Res. 63 2003 3531 3538
21. M.A. Kane, A.E. Folias, C. Wang, and J.L. Napoli Quantitative profiling of endogenous retinoic acid in vivo and in vitro by tandem mass spectrometry Anal. Chem. 80 2008 1702 1708
22. J. Karalliedde, and R.E. Buckingham Thiazolidinediones and their fluid-related adverse effects: facts, fiction and putative management strategies Drug Saf. 30 2007 741 753
23. P.J. Keck, S.D. Hauser, G. Krivi, K. Sanzo, T. Warren, J. Feder, and D.T. Connolly Vascular permeability factor, an endothelial cell mitogen related to PDGF Science 246 1989 1309 1312
24. S.A. Kliewer, K. Umesono, D.J. Noonan, R.A. Heyman, and R.M. Evans Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors Nature 358 1992 771 774
25. S. Lax, T.Z. Hou, E. Jenkinson, M. Salmon, J.R. MacFadyen, C.M. Isacke, G. Anderson, A.F. Cunningham, and C.D. Buckley CD248/Endosialin is dynamically expressed on a subset of stromal cells during lymphoid tissue development, splenic remodeling and repair FEBS Lett. 581 2007 3550 3556
26. J.M. Lehmann, J.M. Lenhard, B.B. Oliver, G.M. Ringold, and S.A. Kliewer Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs J. Biol. Chem. 272 1997 3406 3410
27. D.W. Leung, G. Cachianes, W.J. Kuang, D.V. Goeddel, and N. Ferrara Vascular endothelial growth factor is a secreted angiogenic mitogen Science 246 1989 1306 1309
28. A.A. MILES, and E.M. MILES Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs J. Physiol. 118 1952 228 257
29. S. Nagai, C. Shimizu, M. Umetsu, S. Taniguchi, M. Endo, H. Miyoshi, N. Yoshioka, M. Kubo, and T. Koike Identification of a functional peroxisome proliferator-activated receptor responsive element within the murine perilipin gene Endocrinology 145 2004 2346 2356
30. Q.D. Nguyen, S. Tatlipinar, S.M. Shah, J.A. Haller, E. Quinlan, J. Sung, I. Zimmer-Galler, D.V. Do, and P.A. Campochiaro Vascular endothelial growth factor is a critical stimulus for diabetic macular edema Am. J. Ophthalmol. 142 2006 961 969
31. A. Ohradanova, K. Gradin, M. Barathova, M. Zatovicova, T. Holotnakova, J. Kopacek, S. Parkkila, L. Poellinger, S. Pastorekova, and J. Pastorek Hypoxia upregulates expression of human endosialin gene via hypoxia-inducible factor 2 Br. J. Cancer 99 2008 1348 1356
32. M. Oikawa, M. Abe, H. Kurosawa, W. Hida, K. Shirato, and Y. Sato Hypoxia induces transcription factor ETS-1 via the activity of hypoxia-inducible factor-1 Biochem. Biophys. Res. Commun. 289 2001 39 43
33. J.M. Olefsky Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists J. Clin. Invest. 106 2000 467 472
34. M. Ricote, A.C. Li, T.M. Willson, C.J. Kelly, and C.K. Glass The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79 82
35. E.D. Rosen, P. Sarraf, A.E. Troy, G. Bradwin, K. Moore, D.S. Milstone, B.M. Spiegelman, and R.M. Mortensen PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro Mol. Cell 4 1999 611 617
36. A.R. Saltiel, and J.M. Olefsky Thiazolidinediones in the treatment of insulin resistance and type II diabetes Diabetes 45 1996 1661 1669
37. P. Sartipy, and D.J. Loskutoff Monocyte chemoattractant protein 1 in obesity and insulin resistance Proc. Nat. Acad. Sci. U.S.A. 100 2003 7265 7270
38. D.T. Shima, M. Kuroki, U. Deutsch, Y.S. Ng, A.P. Adamis, and P.A. D'Amore The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences J. Biol. Chem. 271 1996 3877 3883
39. D. Shweiki, A. Itin, D. Soffer, and E. Keshet Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature 359 1992 843 845
40. C. Tsutsumi, M. Okuno, L. Tannous, R. Piantedosi, M. Allan, D.S. Goodman, and W.S. Blaner Retinoids and retinoid-binding protein expression in rat adipocytes J. Biol. Chem. 267 1992 1805 1810
41. A. Whelton Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications Am. J. Med. 106 1999 13S 24S
42. M.S. Wiesener, H. Turley, W.E. Allen, C. Willam, K.U. Eckardt, K.L. Talks, S.M. Wood, K.C. Gatter, A.L. Harris, C.W. Pugh, P.J. Ratcliffe, and P.H. Maxwell Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha Blood 92 1998 2260 2268
43. N.E. Wolins, B.K. Quaynor, J.R. Skinner, A. Tzekov, C. Park, K. Choi, and P.E. Bickel OP9 mouse stromal cells rapidly differentiate into adipocytes: characterization of a useful new model of adipogenesis J. Lipid Res. 47 2006 450 460
44. K. Yamakawa, M. Hosoi, H. Koyama, S. Tanaka, S. Fukumoto, H. Morii, and Y. Nishizawa Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells Biochem. Biophys. Res. Commun. 271 2000 571 574
45. J. Ye, Z. Gao, J. Yin, and Q. He Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice Am. J. Physiol. Endocrinol. Metab. 293 2007 E1118 E1128